Abbott India stock rallies as investors respond to strong recent earnings

Published on 09/18/2026 at 20:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott India stock jumped more than 5 percent on September 18, 2026 as investors reacted to recent double digit profit growth. The move comes after robust revenue and margin performance in the latest reported quarter.

Abbott India, INE358A01014, Illustration mit AI erstellt.

Abbott India (ISIN INE358A01014) stock surged on the National Stock Exchange of India on September 18, 2026, with the shares rallying more than 5 percent intraday as investors continued to respond to strong recent earnings and margin performance in its latest reported quarter.

Stock spikes on September 18, 2026

According to MarketsMojo on September 18, 2026, Abbott India rose 5.34 percent on the day, touching an intraday high of INR 27,490, which represented a 6.1 percent gain from the previous close.

At that snapshot, the stock clearly outperformed its Pharmaceuticals and Biotechnology sector peers, beating the sector performance by 4.7 percentage points as noted by MarketsMojo, underscoring the stock specific momentum rather than a purely sector wide move.

Earnings growth underpins the move

The latest available quarterly results show Abbott India delivering solid growth in both revenue and profit, which helps explain the strong price reaction seen on September 18, 2026. In its most recent reported quarter within fiscal year 2026, Abbott India increased revenue to a level in the high single digit percentage range above the prior year quarter, while net profit expanded at a double digit rate, reflecting operating leverage and improved mix in key therapy areas as reported on its investor relations pages and recent financial portal summaries.

Historical context provides additional color: in fiscal year 2024, Abbott India had already grown its revenue by a double digit percentage compared with fiscal year 2023, and further improved its operating margin by several percentage points, according to company summaries available via its investor relations hub at Abbott India. While these fiscal year 2024 figures are now historical, they frame the trajectory that investors are extrapolating into the current fiscal period.

Sector context and technical picture

Nifty Pharma has been in positive territory, with pharma names contributing to index gains, and Abbott India has been one of the notable contributors in recent sessions, as noted by ET Now News on September 18, 2026.

The same MarketsMojo snapshot highlights that Abbott India is trading above its key moving averages, including short and medium term trend indicators, which technical traders often interpret as confirmation of a bullish trend. For investors, this alignment of improving fundamentals with positive technical signals is an important part of the current story.

Closing price and valuation snapshot

Per equity data for the National Stock Exchange of India around mid session on September 18, 2026, Abbott India shares were trading near INR 27,000, having gained more than 5 percent from the prior close at that point in time, which placed the stock closer to the upper end of its observed 52 week trading range and reflected growing confidence in its earnings outlook.